OSTX

0.80302.12%
JD

Jack Doll

Chief of Staff

Mr. Jack Doll is Chief of Staff of OS Therapies Incorporated from 2023. Mr. Doll is a Research Rock Star and scanning/transmission electron microscope guru. His final research dissertation was on Drug/Antibody-loaded Nanoparticles for Cancer Treatment. A recent Biomaterials and Engineering graduate from the University of Georgia, He assists Dr. Petit on the Osteosarcoma Phase IIb Clinical Trial, as well as the final toxicology trial in Tunable Drug Conjugates.

Positions